Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Redekop

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 14, 2009
Comparing methodologies for the allocation of overhead and capital costs to hospital servicesSiok Swan Tan, Bastianus Martinus van Ineveld, William Ken Redekop, et al.
BMC Health Services Research|January 22, 2016
Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - a case studyLaura T Burgers, Fleur T van de Wetering, Johan L Severens, et al.
Pregnancy Hypertension|July 16, 2021
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in BelgiumAna Dubon Garcia, Roland Devlieger, Ken Redekop, et al.
Plos One|October 2, 2018
Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in IranAmir Ansaripour, Kazem Zendehdel, Niki Tadayon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 22, 2009
Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetesDavid S Cobden, Louis W Niessen, Charles E Barr, et al.
Journal of Pain Research|December 8, 2021
Long-Term Effects of Dexmedetomidine versus Propofol During the Implantation of a Neurostimulator-A Post-Trial Follow-Up AnalysisFeline F J A Ter Bruggen, W Ken Redekop, Dirk L Stronks, et al.
Health Policy (Amsterdam, Netherlands)|November 27, 2004
Quality based social insurance coverage and payment of the application of a high cost medical therapy: the case of spinal cord stimulation for chronic non-oncologic pain in The NetherlandsNicoline Beersen, W Ken Redekop, J H Bart de Bruijn, et al.
Pharmacoeconomics|May 4, 2013
The development and validation of a decision-analytic model representing the full disease course of acute myeloid leukemiaAnnemieke Leunis, W Ken Redekop, Kees A G M van Montfort, et al.
World Journal of Clinical Cases|November 25, 2015
Cost-effectiveness in Clostridium difficile treatment decision-makingMark Jc Nuijten, Josbert J Keller, Caroline E Visser, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 4, 2011
A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care givingRenske J Hoefman, N Job A van Exel, Sandra Looren de Jong, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 14, 2009
Comparing methodologies for the allocation of overhead and capital costs to hospital servicesSiok Swan Tan, Bastianus Martinus van Ineveld, William Ken Redekop, et al.
BMC Health Services Research|January 22, 2016
Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - a case studyLaura T Burgers, Fleur T van de Wetering, Johan L Severens, et al.
Pregnancy Hypertension|July 16, 2021
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in BelgiumAna Dubon Garcia, Roland Devlieger, Ken Redekop, et al.
Plos One|October 2, 2018
Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in IranAmir Ansaripour, Kazem Zendehdel, Niki Tadayon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 22, 2009
Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetesDavid S Cobden, Louis W Niessen, Charles E Barr, et al.
Journal of Pain Research|December 8, 2021
Long-Term Effects of Dexmedetomidine versus Propofol During the Implantation of a Neurostimulator-A Post-Trial Follow-Up AnalysisFeline F J A Ter Bruggen, W Ken Redekop, Dirk L Stronks, et al.
Health Policy (Amsterdam, Netherlands)|November 27, 2004
Quality based social insurance coverage and payment of the application of a high cost medical therapy: the case of spinal cord stimulation for chronic non-oncologic pain in The NetherlandsNicoline Beersen, W Ken Redekop, J H Bart de Bruijn, et al.
Pharmacoeconomics|May 4, 2013
The development and validation of a decision-analytic model representing the full disease course of acute myeloid leukemiaAnnemieke Leunis, W Ken Redekop, Kees A G M van Montfort, et al.
World Journal of Clinical Cases|November 25, 2015
Cost-effectiveness in Clostridium difficile treatment decision-makingMark Jc Nuijten, Josbert J Keller, Caroline E Visser, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 4, 2011
A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care givingRenske J Hoefman, N Job A van Exel, Sandra Looren de Jong, et al.
Pageof 9